Skip to main content
Avricore Health Inc. logo

Avricore Health Inc. — Investor Relations & Filings

Ticker · AVCR ISIN · CA0545211090 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 138 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country CA Canada
Listing TSXV AVCR

About Avricore Health Inc.

https://avricore.com/

Avricore Health Inc. is a pharmacy services innovator specializing in health data and point-of-care technologies. The company develops and provides turnkey digital solutions to support the expanding clinical role of pharmacists and enhance community access to healthcare services. Its flagship product is HealthTab™, a point-of-care testing platform that combines lab-accurate rapid testing for up to 27 biomarkers (including chronic and infectious disease screening) with a secure, cloud-based system for result tracking. The HealthTab network serves as a data-driven infrastructure, collecting real-time, deidentified patient data (Real World Evidence) that can be customized and integrated via API for use by health organizations and clinical trials groups.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-04-21 English
News release - English.pdf
Regulatory Filings
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Avricore Health announcing the expansion of its HealthTab platform into new pharmacy sites. It follows the standard format of a corporate news release, including a headline, dateline, company description, and a cautionary note regarding forward-looking statements. Since it does not fit into specific categories like financial reports, proxy statements, or director dealings, and is a general corporate announcement, it is classified as a Regulatory Filing (RNS).
2026-01-14 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Avricore Health announcing a new pilot program for their HealthTab technology within the NHS. It details business developments, strategic partnerships, and operational expansions. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement. As it is a general corporate announcement regarding business activities and partnerships, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2025-11-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 basic certificate under Canadian securities law certifying the review and fair presentation of interim filings (financial report and MD&A). It is not the interim financial report itself, nor an earnings release or MD&A, but rather a standalone certification required by regulation. It does not contain substantive financial data or management discussion beyond the certification. Therefore, it is best classified as a general regulatory filing (fallback).
2025-08-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 Venture Issuer Basic Certificate certifying the review of the interim financial report and interim MD&A for the period ended June 30, 2025. It is not the interim report itself, but a statutory certificate filed under NI 52-109 alongside interim filings. There is no standalone category for certification forms, so this is best classified as a general Regulatory Filing (RNS).
2025-08-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.